 |
|
recombinant nematode anticoagulant protein c2
An 85-amino acid recombinant peptide derived from protein c2 of the hemophagocytic hookworm Ancylostoma caninum (a common canine parasite) with anticoagulant activity. Recombinant nematode anticoagulant protein c2 (rNAPc2) binds to circulating activated factior X (FXa) or zymogen factor X (FX) to form a binary complex which subsequently binds to and inhibits membrane-bound activated factor VII/tissue factor complex (FVIIa/TF). When administered prophylactically, this agent may reduce the incidence of deep venous thrombosis without hemostatic compromise. Because rNAPc2 inhibits the formation of the FVIIa/TF protease complex, which may play a role in the cellular signaling of both metastatic and angiogenic processes, it may impede tumor progression. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Acronym: | | rNAPc2 | | |
| Previous: | recombinant interleukin-7, recombinant macrophage colony-stimulating factor, recombinant MAGE-3.1 antigen, recombinant MAGE-A3 antigen-specific cancer immunotherapeutic GSK1203486A, recombinant modified vaccinia Ankara-5T4 vaccine | | Next: | recombinant parathyroid hormone, recombinant platelet factor 4, recombinant soluble human CD4 protein, recombinant thyroid-stimulating hormone, recombinant thyrotropin alfa |
|
|
